HSHHSH Health Technology Supplier Hub
Home › Suppliers › IBM › Risk

IBM: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

FY2025 revenue $67.53bn (+7.6%); pre-tax margin 15.3%; net income $10.59bn.

Cash $14.50bn; debt $61.30bn.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

Jun 2026: a False Claims Act lawsuit by a former IBM threat-intelligence executive was unsealed, alleging IBM concealed foreign hacks of systems used by US government customers; the DOJ declined to intervene and IBM said it is confident it complied with the law.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

Jun 2026: an unsealed whistleblower lawsuit alleges IBM failed to disclose repeated breaches by foreign state-backed hackers (including APT10, 2013-2016) to US government customers; IBM says it complied with the law. No regulator action found. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

IT services and software supplier; no regulatory or clinical safety actions found in the last 24 months.

Researched 10 Nov 2026